Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Slicing the pie: Advances in targeted therapy for oncogene-addicted NSCLC

New therapies and questions for EGFR, Exon 20 and HER2 mutation

Date

10 Sep 2022

Session

Slicing the pie: Advances in targeted therapy for oncogene-addicted NSCLC

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Zofia Piotrowska

Authors

Z. Piotrowska

Author affiliations

  • Hematology/oncology Dept., MGH - Massachusetts General Hospital, 02114 - Boston/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

How to address resistance

Presenter: Joop De Langen

Session: Slicing the pie: Advances in targeted therapy for oncogene-addicted NSCLC

Resources:

Slides

Webcast

Where does IO fit in?

Presenter: Rina Hui

Session: Slicing the pie: Advances in targeted therapy for oncogene-addicted NSCLC

Resources:

Slides

Webcast

Conclusions and perspectives 

Presenter: Zofia Piotrowska

Session: Slicing the pie: Advances in targeted therapy for oncogene-addicted NSCLC

Resources:

Slides

Webcast

Discussion

Presenter: All Speakers

Session: Slicing the pie: Advances in targeted therapy for oncogene-addicted NSCLC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.